SAB BIOTHERAPEUTICS, INC. (SABSW) Total liabilities 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABSW) total liabilities at each fiscal year-end, per SEC filings.
$21.3MFY2025 · since FY2020: $17.5M → $21.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $21.3M | +16.9% |
| FY2024 | $18.2M | -31.6% |
| FY2023 | $26.6M | +34.2% |
| FY2022 | $19.8M | -53.4% |
| FY2021 | $42.6M | +143.0% |
| FY2020 | $17.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SABSW financial trends
SABSW RevenueSABSW Net incomeSABSW Net marginSABSW Gross profitSABSW Gross marginSABSW Operating incomeSABSW Operating marginSABSW Operating cash flowSABSW Free cash flowSABSW Capital expendituresSABSW Return on equitySABSW Stock buybacksSABSW Dividends paidSABSW Total assetsSABSW Shareholders’ equitySABSW overview →